The study identified mutations in senescence-associated genes, namely, ATM, PIF1, TELO2, XAF1, and RBL1, in five of twenty subjects with multiple adenomas, indicating germline loss-of-function variants in genes that regulate senescence pathways with the development of serrated adenomas [50]. The gene discussed is RBL1; the disease is adenoma.